Nephrology Medical News about Cardiovascular Diseases Pravastatin Kidney Failure, Chronic

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09

Nakamura H et al. – Risk of CVD is higher in patients with moderate CKD compared with those with normal renal function/mild CKD, and was significantly reduced by treatment with pravastatin. Pravastatin also exerted beneficial effects on renal function in patients with moderate CKD.

<< Previous
CCHIT Revamping EHR Certification

Next >>
The ADVANCE Trial: Clarifying the Role of Perindopril/Indapamide...

The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study
BMC Cardiovascular Disorders, 11/13/09 Relevance Score: 94%

Is normalising haemoglobin in patients with CKD harmful and if so, why
Journal of Renal Care, 11/17/09 Relevance Score: 93%

Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease
Nephrology Dialysis Transplantation, 11/12/09 Relevance Score: 93%

Rapid Decline of Kidney Function Increases Cardiovascular Risk in the Elderly
Journal of the American Society of Nephrology, 11/09/09 Relevance Score: 93%

Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events
Clinical and Experimental Nephrology, 11/06/09 Relevance Score: 93%